Exceptions of prbc transfusion at 15ml per kg

Reading File
Reading File
Searching the Web

pediatric red blood cell transfusion 15 mL/kg exceptions cardiac renal neonate guideline

Searching PubMed

pediatric red blood cell transfusion

Finding Sources
For most stable children, PRBC 10-15 mL/kg is used, commonly rounded to 15 mL/kg. Exceptions are mainly situations where either volume must be restricted or blood loss is ongoing:
SituationUsual modification
Heart failure, significant congenital heart disease, renal failure, or fluid overload riskGive smaller aliquots, often 5-10 mL/kg, slowly, with reassessment between aliquots. Consider diuretic only when clinically indicated.
Severe chronic anemia such as longstanding iron-deficiency anemia, where cardiac failure is a concernSmall, slow aliquots such as 2-5 mL/kg at a time, reassessing clinically. Avoid rapidly correcting Hb to normal.
Neonates / preterm infantsUsually 10-15 mL/kg per top-up transfusion; use neonatal blood-bank specifications.
Active major hemorrhage / shockA fixed 15 mL/kg dose may be inadequate. Give resuscitation according to pediatric massive-hemorrhage protocol, commonly 10-20 mL/kg PRBC, guided by ongoing loss, hemodynamics, Hb, coagulation, calcium, and temperature.
Exchange transfusion for neonatal hyperbilirubinemia or selected sickle-cell indicationsThis is not a simple 15 mL/kg top-up transfusion. It follows an exchange-transfusion protocol.
ECMO, cardiopulmonary bypass, or intraoperative transfusionVolume and targets are individualized by the surgical/critical-care protocol.
Also distinguish PRBC concentration: a dose of 10-15 mL/kg is typical for additive-solution RBCs, while higher-hematocrit products may use a smaller volume. The AABB component guide lists pediatric RBC doses in this range.
Use the child’s local transfusion policy, current Hb, symptoms, cardiac/renal status, and post-transfusion reassessment rather than treating 15 mL/kg as automatic. Recent evidence in congenital-heart surgery remains insufficient to define one universal approach, supporting individualized management (Cochrane review, PMID 40105353).
This is a shared conversation. Sign in to Orris to start your own chat.